查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1402891

數位 PCR 和定量 PCR 市場 - 2023-2031 年全球產業分析、規模、佔有率、成長、趨勢和預測

Digital PCR and Quantitative PCR Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 160 Pages | 商品交期: 2-10個工作天內

價格

數位 PCR (dPCR) 和定量 PCR (qPCR) 市場 - 報告範圍

TMR 關於全球數位 PCR (dPCR) 和定量 PCR (qPCR) 市場的報告研究了過去和當前的成長趨勢以及機會，以獲得 2023 年至 2031 年預測期內市場指標的寶貴見解。該報告提供了2017- 2031年全球數位PCR（dPCR）和定量PCR（qPCR）市場的收入，以2023年為基準年，2031年為預測年。報告中也提供了2023年至2031年全球數位PCR（dPCR）和定量PCR（qPCR）市場的年複合成長率（CAGR %）。

該報告是經過廣泛研究後編寫的。初級研究涉及大部分研究工作，其中分析師對關鍵意見領袖、行業領導者和輿論製造者進行了採訪。二次研究涉及參考主要參與者的產品文獻、年度報告、新聞稿和相關文件，以了解數位 PCR (dPCR) 和定量 PCR (qPCR) 市場。

市場概況
2023年市場價值 43 億美元
2031 年市場價值 75 億美元
CAGR 6.3%

該報告深入探討了全球數位 PCR (dPCR) 和定量 PCR (qPCR) 市場的競爭格局。全球數位 PCR (dPCR) 和定量 PCR (qPCR) 市場中的主要參與者已被確定，並且每位參與者都已根據各種屬性進行了分析。公司概況、財務狀況、最新發展和 SWOT 是本報告中介紹的全球數位 PCR (dPCR) 和定量 PCR (qPCR) 市場參與者的屬性。

目錄

第1章：前言

第 2 章：假設與研究方法

第 3 章：執行摘要：全球市場

第 4 章：市場概覽

  • 介紹
  • 概述
  • 市場動態
  • 2023-2031年全球市場分析與預測

第 5 章：關鍵見解

  • 即時 PCR 在連續性照護和病患管理的應用。
  • dPCR 和 qPCR 的優勢
  • 主要產品/品牌分析
  • 技術進步
  • 市場空間中排名前三的參與者
  • 新冠疫情影響分析

第 6 章：全球市場分析與預測：依產品類型

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：依產品類型，2023-2031
    • 定量PCR
      • 試劑及耗材
      • 儀器
      • 軟體
    • 數位PCR
      • 試劑及耗材
      • 儀器
      • 軟體
  • 市場吸引力分析：按產品類型

第 7 章：全球市場分析與預測：按應用分類

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：依應用分類，2023-2031
    • 臨床應用
    • 研究應用
    • 病原體檢測
    • 腫瘤學測試
    • 血液篩檢
    • 其他
  • 市場吸引力分析：按應用

第 8 章：全球市場分析與預測：按最終用戶

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：按最終用戶，2023-2031
    • 醫院和診斷中心
    • 研究實驗室和學術機構
    • 製藥與生物技術公司
    • 臨床研究組織
    • 其他
  • 市場吸引力分析：按最終用戶

第 9 章：全球市場分析與預測：按地區

  • 主要發現
  • 市場價值預測：按地區
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力分析：按地區

第 10 章：北美市場分析與預測

第 11 章：歐洲市場分析與預測

第 12 章：亞太市場分析與預測

第 13 章：拉丁美洲市場分析與預測

第 14 章：中東和非洲市場分析與預測

第15章：競爭格局

  • 市場參與者 - 競爭矩陣（依公司層級和規模）
  • 市佔率分析：依公司分類（2021 年）
  • 公司簡介
    • Bio Rad Laboratories
    • Thermo Fisher Scientific, Inc.
    • Qiagen
    • F. Hoffmann La Roche Ltd.
    • Abbott Laboratories
    • Agilent Technologies
    • BD
    • Danaher Corporation
    • Merck KGaA
    • Takara Bio, Inc.
Product Code: TMRGL17423

Digital PCR (dPCR) and Quantitative PCR (qPCR) Market - Scope of Report

TMR's report on the global digital PCR (dPCR) and quantitative PCR (qPCR) market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global digital PCR (dPCR) and quantitative PCR (qPCR) market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global digital PCR (dPCR) and quantitative PCR (qPCR) market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the digital PCR (dPCR) and quantitative PCR (qPCR) market.

Market Snapshot
Market Value in 2023US$ 4.3 Bn
Market Value in 2031US$ 7.5 Bn
CAGR6.3%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global digital PCR (dPCR) and quantitative PCR (qPCR) market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global digital PCR (dPCR) and quantitative PCR (qPCR) market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global digital PCR (dPCR) and quantitative PCR (qPCR) market.

The report delves into the competitive landscape of the global digital PCR (dPCR) and quantitative PCR (qPCR) market. Key players operating in the global digital PCR (dPCR) and quantitative PCR (qPCR) market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global digital PCR (dPCR) and quantitative PCR (qPCR) market profiled in this report.

Key Questions Answered in Global digital PCR (dPCR) and quantitative PCR (qPCR) Market Report:

  • What is the sales/revenue generated by digital PCR (dPCR) and quantitative PCR (qPCR) across all regions during the forecast period?
  • What are the opportunities in the global digital PCR (dPCR) and quantitative PCR (qPCR) market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Digital PCR (dPCR) and Quantitative PCR (qPCR) Market - Research Objectives and Research Approach

The comprehensive report on the global digital PCR (dPCR) and quantitative PCR (qPCR) market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global digital PCR (dPCR) and quantitative PCR (qPCR) market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global digital PCR (dPCR) and quantitative PCR (qPCR) market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast, 2023-2031

5. Key Insights

  • 5.1. Applications of real-time PCR in the continuum of care and patient management.
  • 5.2. Strengths of dPCR and qPCR
  • 5.3. Key product/brand Analysis
  • 5.4. Technological Advancements
  • 5.5. Top 3 players operating in the market space
  • 5.6. COVID Impact Analysis

6. Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast, by Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Product Type, 2023-2031
    • 6.3.1. Quantitative PCR
      • 6.3.1.1. Reagents & Consumables
      • 6.3.1.2. Instruments
      • 6.3.1.3. Software
    • 6.3.2. Digital PCR
      • 6.3.2.1. Reagents & Consumables
      • 6.3.2.2. Instruments
      • 6.3.2.3. Software
  • 6.4. Market Attractiveness Analysis, by Product Type

7. Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast, by Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Application, 2023-2031
    • 7.3.1. Clinical Applications
    • 7.3.2. Research Applications
    • 7.3.3. Pathogen Testing
    • 7.3.4. Oncology Testing
    • 7.3.5. Blood Screening
    • 7.3.6. Others
  • 7.4. Market Attractiveness Analysis, by Application

8. Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by End-user, 2023-2031
    • 8.3.1. Hospitals & Diagnostic Centers
    • 8.3.2. Research Laboratories & Academic Institutes
    • 8.3.3. Pharmaceutical & Biotechnology Companies
    • 8.3.4. Clinical Research Organizations
    • 8.3.5. Others
  • 8.4. Market Attractiveness Analysis, by End-user

9. Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Product Type, 2023-2031
    • 10.2.1. Quantitative PCR
      • 10.2.1.1. Reagents & Consumables
      • 10.2.1.2. Instruments
      • 10.2.1.3. Software
    • 10.2.2. Digital PCR
      • 10.2.2.1. Reagents & Consumables
      • 10.2.2.2. Instruments
      • 10.2.2.3. Software
  • 10.3. Market Value Forecast, by Application, 2023-2031
    • 10.3.1. Clinical Applications
    • 10.3.2. Research Applications
    • 10.3.3. Pathogen Testing
    • 10.3.4. Oncology Testing
    • 10.3.5. Blood Screening
    • 10.3.6. Others
  • 10.4. Market Value Forecast, by End-user, 2023-2031
    • 10.4.1. Hospitals & Diagnostic Centers
    • 10.4.2. Research Laboratories & Academic Institutes
    • 10.4.3. Pharmaceutical & Biotechnology Companies
    • 10.4.4. Clinical Research Organizations
    • 10.4.5. Others
  • 10.5. Market Value Forecast, by Country, 2023-2031
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Product Type
    • 10.6.2. By Application
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product Type, 2023-2031
    • 11.2.1. Quantitative PCR
      • 11.2.1.1. Reagents & Consumables
      • 11.2.1.2. Instruments
      • 11.2.1.3. Software
    • 11.2.2. Digital PCR
      • 11.2.2.1. Reagents & Consumables
      • 11.2.2.2. Instruments
      • 11.2.2.3. Software
  • 11.3. Market Value Forecast, by Application, 2023-2031
    • 11.3.1. Clinical Applications
    • 11.3.2. Research Applications
    • 11.3.3. Pathogen Testing
    • 11.3.4. Oncology Testing
    • 11.3.5. Blood Screening
    • 11.3.6. Others
  • 11.4. Market Value Forecast, by End-user, 2023-2031
    • 11.4.1. Hospitals & Diagnostic Centers
    • 11.4.2. Research Laboratories & Academic Institutes
    • 11.4.3. Pharmaceutical & Biotechnology Companies
    • 11.4.4. Clinical Research Organizations
    • 11.4.5. Others
  • 11.5. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Product Type
    • 11.6.2. By Application
    • 11.6.3. By End-user
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product Type, 2023-2031
    • 12.2.1. Quantitative PCR
      • 12.2.1.1. Reagents & Consumables
      • 12.2.1.2. Instruments
      • 12.2.1.3. Software
    • 12.2.2. Digital PCR
      • 12.2.2.1. Reagents & Consumables
      • 12.2.2.2. Instruments
      • 12.2.2.3. Software
  • 12.3. Market Value Forecast, by Application, 2023-2031
    • 12.3.1. Clinical Applications
    • 12.3.2. Research Applications
    • 12.3.3. Pathogen Testing
    • 12.3.4. Oncology Testing
    • 12.3.5. Blood Screening
    • 12.3.6. Others
  • 12.4. Market Value Forecast, by End-user, 2023-2031
    • 12.4.1. Hospitals & Diagnostic Centers
    • 12.4.2. Research Laboratories & Academic Institutes
    • 12.4.3. Pharmaceutical & Biotechnology Companies
    • 12.4.4. Clinical Research Organizations
    • 12.4.5. Others
  • 12.5. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 12.5.1. China
    • 12.5.2. India
    • 12.5.3. Japan
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Product Type
    • 12.6.2. By Application
    • 12.6.3. By End-user
    • 12.6.4. By Country/Sub-region

13. Latin America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product Type, 2023-2031
    • 13.2.1. Quantitative PCR
      • 13.2.1.1. Reagents & Consumables
      • 13.2.1.2. Instruments
      • 13.2.1.3. Software
    • 13.2.2. Digital PCR
      • 13.2.2.1. Reagents & Consumables
      • 13.2.2.2. Instruments
      • 13.2.2.3. Software
  • 13.3. Market Value Forecast, by Application, 2023-2031
    • 13.3.1. Clinical Applications
    • 13.3.2. Research Applications
    • 13.3.3. Pathogen Testing
    • 13.3.4. Oncology Testing
    • 13.3.5. Blood Screening
    • 13.3.6. Others
  • 13.4. Market Value Forecast, by End-user, 2023-2031
    • 13.4.1. Hospitals & Diagnostic Centers
    • 13.4.2. Research Laboratories & Academic Institutes
    • 13.4.3. Pharmaceutical & Biotechnology Companies
    • 13.4.4. Clinical Research Organizations
    • 13.4.5. Others
  • 13.5. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Product Type
    • 13.6.2. By Application
    • 13.6.3. By End-user
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product Type, 2023-2031
    • 14.2.1. Quantitative PCR
      • 14.2.1.1. Reagents & Consumables
      • 14.2.1.2. Instruments
      • 14.2.1.3. Software
    • 14.2.2. Digital PCR
      • 14.2.2.1. Reagents & Consumables
      • 14.2.2.2. Instruments
      • 14.2.2.3. Software
  • 14.3. Market Value Forecast, by Application, 2023-2031
    • 14.3.1. Clinical Applications
    • 14.3.2. Research Applications
    • 14.3.3. Pathogen Testing
    • 14.3.4. Oncology Testing
    • 14.3.5. Blood Screening
    • 14.3.6. Others
  • 14.4. Market Value Forecast, by End-user, 2023-2031
    • 14.4.1. Hospitals & Diagnostic Centers
    • 14.4.2. Research Laboratories & Academic Institutes
    • 14.4.3. Pharmaceutical & Biotechnology Companies
    • 14.4.4. Clinical Research Organizations
    • 14.4.5. Others
  • 14.5. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Product Type
    • 14.6.2. By Application
    • 14.6.3. By End-user
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (by tier and size of companies)
  • 15.2. Market Share Analysis, by Company (2021)
  • 15.3. Company Profiles
    • 15.3.1. Bio Rad Laboratories
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. Financial Overview
      • 15.3.1.4. SWOT Analysis
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Thermo Fisher Scientific, Inc.
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. Financial Overview
      • 15.3.2.4. SWOT Analysis
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Qiagen
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. Financial Overview
      • 15.3.3.4. SWOT Analysis
      • 15.3.3.5. Strategic Overview
    • 15.3.4. F. Hoffmann La Roche Ltd.
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. Financial Overview
      • 15.3.4.4. SWOT Analysis
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Abbott Laboratories
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. Financial Overview
      • 15.3.5.4. SWOT Analysis
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Agilent Technologies
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. Financial Overview
      • 15.3.6.4. SWOT Analysis
      • 15.3.6.5. Strategic Overview
    • 15.3.7. BD
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. Financial Overview
      • 15.3.7.4. SWOT Analysis
      • 15.3.7.5. Strategic Overview
    • 15.3.8. Danaher Corporation
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. Financial Overview
      • 15.3.8.4. SWOT Analysis
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Merck KGaA
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Product Portfolio
      • 15.3.9.3. Financial Overview
      • 15.3.9.4. SWOT Analysis
      • 15.3.9.5. Strategic Overview
    • 15.3.10. Takara Bio, Inc.
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Product Portfolio
      • 15.3.10.3. Financial Overview
      • 15.3.10.4. SWOT Analysis
      • 15.3.10.5. Strategic Overview

List of Tables

  • Table 01: Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by Product Type, 2023-2031
  • Table 02: Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by Application, 2023-2031
  • Table 03: Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 04: Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by Region, 2023-2031
  • Table 05: North America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by Product Type, 2023-2031
  • Table 06: North America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by Application, 2023-2031
  • Table 07: North America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 08: North America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by Country, 2023-2031
  • Table 09: Europe Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by Product Type, 2023-2031
  • Table 10: Europe Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by Application, 2023-2031
  • Table 11: Europe Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 12: Europe Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 13: Asia Pacific Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by Product Type, 2023-2031
  • Table 14: Asia Pacific Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by Application, 2023-2031
  • Table 15: Asia Pacific Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 16: Asia Pacific Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 17: Latin America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by Product Type, 2023-2031
  • Table 18: Latin America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by Application, 2023-2031
  • Table 19: Latin America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 20: Latin America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 21: Middle East & Africa Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by Product Type, 2023-2031
  • Table 22: Middle East & Africa Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by Application, 2023-2031
  • Table 23: Middle East & Africa Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 24: Middle East & Africa Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031

List of Figures

  • Figure 1 : Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast 2023-2031
  • Figure 2 : Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value Share by Product Type 2022
  • Figure 3 : Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value Share by Application 2022
  • Figure 4 : Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value Share by End-user 2022
  • Figure 5 : Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value Share Analysis by Product Type 2022 and 2031
  • Figure 6 : Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Revenue (US$ Mn) by Quantitative PCR 2017-2031
  • Figure 7 : Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Revenue (US$ Mn) by Digital PCR 2017-2031
  • Figure 8 : Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Attractiveness Analysis, by Application 2023-2031
  • Figure 9 : Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value Share Analysis by Application 2022 and 2031
  • Figure 10: Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Revenue (US$ Mn) by Clinical Applications 2017-2031
  • Figure 11: Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Revenue (US$ Mn) by Pathogen Testing 2017-2031
  • Figure 12: Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Revenue (US$ Mn) by Oncology Testing 2017-2031
  • Figure 13: Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Revenue (US$ Mn) by Research Applications 2017-2031
  • Figure 14: Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Revenue (US$ Mn) by Blood Screening 2017-2031
  • Figure 15: Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Revenue (US$ Mn) by Others 2017-2031
  • Figure 16: Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Attractiveness Analysis, by End-user 2023-2031
  • Figure 17: Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value Share Analysis by End-user 2022 and 2031
  • Figure 18: Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Revenue (US$ Mn) by Hospitals & Diagnostic Centers 2017-2031
  • Figure 19: Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Revenue (US$ Mn) by Research Laboratories & Academic Institutes 2017-2031
  • Figure 20: Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Revenue (US$ Mn) by Pharmaceutical & Biotechnology Companies 2017-2032
  • Figure 21: Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Revenue (US$ Mn) by Clinical Research Organizations 2017-2032
  • Figure 22: Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Revenue (US$ Mn) by Others 2017-2032
  • Figure 23: Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value Share Analysis by Region 2022 and 2031
  • Figure 24: Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Attractiveness Analysis, by Region 2023-2031
  • Figure 25: North America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast 2017-2031
  • Figure 26: North America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value Share Analysis by Country 2022 and 2031
  • Figure 27: North America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Attractiveness Analysis, by Country 2023-2031
  • Figure 28: North America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value Share Analysis by Product Type 2022 and 2031
  • Figure 29: North America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Attractiveness Analysis, by Product Type 2023-2031
  • Figure 30: North America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value Share Analysis by Application 2022 and 2031
  • Figure 31: North America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Attractiveness Analysis, by Application 2023-2031
  • Figure 32: North America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value Share Analysis by End-user 2022 and 2031
  • Figure 33: North America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Attractiveness Analysis, by End-user 2023-2031
  • Figure 34: Europe Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast 2023-2031
  • Figure 35: Europe Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value Share Analysis by Country/Sub-region, 2022 and 2031
  • Figure 36: Europe Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 37: Europe Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value Share Analysis by Product Type 2022 and 2031
  • Figure 38: Europe Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Attractiveness Analysis, by Product Type 2023-2031
  • Figure 39: Europe Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value Share Analysis by Application 2022 and 2031
  • Figure 40: Europe Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Attractiveness Analysis, by Application 2023-2031
  • Figure 41: Europe Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value Share Analysis by End-user 2022 and 2031
  • Figure 42: Europe Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Attractiveness Analysis, by End-user 2023-2031
  • Figure 43: Asia Pacific Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast 2023-2031
  • Figure 44: Asia Pacific Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value Share Analysis by Country/Sub-region, 2022 and 2031
  • Figure 45: Asia Pacific Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 46: Asia Pacific Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value Share Analysis by Product Type 2022 and 2031
  • Figure 47: Asia Pacific Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Attractiveness Analysis, by Product Type 2023-2031
  • Figure 48: Asia Pacific Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value Share Analysis by Application 2022 and 2031
  • Figure 49: Asia Pacific Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Attractiveness Analysis, by Application 2023-2031
  • Figure 50: Asia Pacific Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value Share Analysis by End-user 2022 and 2031
  • Figure 51: Asia Pacific Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Attractiveness Analysis, by End-user 2023-2031
  • Figure 52: Latin America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) Forecast 2023-2031
  • Figure 53: Latin America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value Share Analysis by Country/Sub-region, 2022 and 2031
  • Figure 54: Latin America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 55: Latin America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value Share Analysis by Product Type 2022 and 2031
  • Figure 56: Latin America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Attractiveness Analysis, by Product Type 2023-2031
  • Figure 57: Latin America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value Share Analysis by Application 2022 and 2031
  • Figure 58: Latin America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Attractiveness Analysis, by Application 2023-2031
  • Figure 59: Latin America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value Share Analysis by End-user 2022 and 2031
  • Figure 60: Latin America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Attractiveness Analysis, by End-user 2023-2031
  • Figure 61: Middle East & Africa Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value (US$ Mn) 2017-2031
  • Figure 62: Middle East & Africa Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value Share Analysis by Country/Sub-region 2022 and 2031
  • Figure 63: Middle East & Africa Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Attractiveness by Country/Sub-region 2023-2031
  • Figure 64: Middle East & Africa Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value Share Analysis by Product Type 2022 and 2031
  • Figure 65: Middle East & Africa Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Attractiveness by Product Type 2023-2031
  • Figure 66: Middle East & Africa Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value Share Analysis by Application 2022 and 2031
  • Figure 67: Middle East & Africa Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Attractiveness by Application 2023-2031
  • Figure 68: Middle East & Africa Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Value Share Analysis by End-user 2022 and 2031
  • Figure 69: Middle East & Africa Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Attractiveness by End-user 2023-2031